All UK & Rest of Europe articles
-
NewsLocal microbes persist in wine despite commercial yeast
A new study has demonstrated that regional microbial imprints can remain detectable under commercial winemaking conditions. The new research shows that inoculated fermentations do not “override” native microbial diversity and that vineyard management and environmental conditions matter in wine quality.
-
NewsAMI welcomes new member to its Board of Trustees
Applied Microbiology International has welcomed Professor Les Baillie as the latest member of its Board of Trustees. We also bid a fond farewell and thank you to Professor Diane Purchase who is leaving the Board.
-
NewsThousands of new findings contribute to a global virus map
An extensive study has mapped RNA viruses in a large number of cities around the world. The researchers identified nearly 55,000 different types of virus, the vast majority of which had never been observed before. The virus atlas could be useful in both biological risk assessment and crime scene investigations.
-
NewsPlant health: New joint factsheet outlines synergy between Horizon Europe projects FORSAID, CERBERUS and STELLA
One of the biggest threats to Europe’s forests and farms is the spread of biotic stressors, capable of reversing decades of cultivation and conservation. As part of its efforts to address this challenge, the EU has mobilised three sister projects - FORSAID, CERBERUS and STELLA.
-
NewsAMI calls for marine microbes to be at the heart of Europe’s future ocean policy
Applied Microbiology International (AMI) has responded to the European Commission’s consultation on the proposed EU Ocean Act, highlighting the essential contribution of marine microorganisms to ocean health, climate regulation, biodiversity and the blue bioeconomy.
-
NewsHeatwaves inhibit antibiotic resistance in soils - but at a price
Heatwaves temporarily reduce the amount of resistance genes in the soil, but heat and droughts are also causing significant damage to soils and ecosystems. The temporary dip in resistance therefore does not mean that the health risks from antibiotic resistance disappear.
-
NewsFaster diagnostics, deeper insights: Researchers strengthen response to Ebola outbreaks
Two studies provide important insights into the challenges of responding to outbreaks - one demonstrates how diagnostic tests can be evaluated rapidly during an outbreak; the other investigates the biological properties of the 2026 BDBV strain and whether an existing Ebola vaccine could offer cross-protection.
-
NewsCommonly used cancer drugs boost MRSA antibiotics – new research
Scientists tested five anti-cancer drugs and revealed that four of them helped penicillin-type antibiotics to kill MRSA. These drugs interfere with the bacteria’s ability to make DNA, making the bacteria more vulnerable to the antibiotics.
-
NewsMpox outbreak in 2022 caused by less severe form of the virus
The strain of Mpox behind the 2022 outbreak was a weakened form of the virus, which may have helped to spread it faster, a new study reports. The findings show that the virus acquired mutations before it spread globally.
-
NewsSuper-resolution imaging reveals details inside living cells
A new fluorescence microscopy technique that generates super-resolution images from a single camera exposure could help researchers study rapid movements within cells that are difficult to capture with existing methods.
-
NewsHigh-dose flu vaccine beneficial for older people with lung disease
The risk of being hospitalised for flu or pneumonia can be reduced with a high-dose flu vaccine for older people with chronic lung disease, according to the combined results of two large clinical trials.
-
NewsFrom soil to outer space: our interview with JAM Systems Microbiology Lead Editor Janet Jansson
We get to know Janet Jansson, who has been appointed as new Lead Editor in Systems Microbiology at the Journal of Applied Microbiology.
-
NewsHaving COVID-19 is associated with lower subsequent development of type 1 diabetes among those aged under 30 years
New research shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequent development of type 1 diabetes (T1D). Furthermore, the effect is evident only in people who did not receive the SARS-CoV-2 vaccine.
-
NewsMember Q&A: Harta Wedari on how AMI has opened up new opportunities and communities
Dr Ni Luh Putu Harta Wedari, a medical doctor and Clinical Microbiology Specialist from Bali, Indonesia reveals how engaging with AMI has expanded her international network and unveiled new opportunities.
-
NewsMeningitis, hangover or freshers’ flu? Don’t dismiss serious symptoms
Students heading into freshers’ week are being warned not to assume a headache, vomiting or feeling wiped out is simply the result of a heavy night or the dreaded “freshers’ flu”. 246,089 doses of the MenB vaccine were administered to young people in England between 20 July and 31 August.
-
NewsBacteria in classroom dust associated with reduced lung function in children
Common bacteria found in classroom dust are associated with reduced lung function in children according to new research, Children in classrooms with higher levels of Streptomyces had a 0.08 litres lower forced vital capacity (FVC).
-
NewsScientists discover link between gut bacteria and severe liver disease
Researchers have identified what may potentially be a missing link between specific activities in gut bacteria and the liver disease primary sclerosing cholangitis: the metabolite ImP, a molecule formed when certain gut bacteria break down dietary components.
-
NewsInternational award supports research into fern-microbe symbiosis
Dr Sophie de Vries will combine evolutionary genomics with experiments that pair ferns and different microbes, to investigate how plants fight off “foes” (diseases) at the same time as supporting their beneficial “friendships” (bacterial partners).
-
NewsThe body doesn’t just absorb a plant-based diet—it adapts to one, new review finds
A new review of plant-based diets concludes that the body actively adapts to sustained dietary change, absorbing iron more efficiently, synthesizing more of its own creatine and carnosine, using protein more economically, and remodeling gut bacteria to better ferment fiber.
-
NewsMicro-bladder model offers clues to stopping recurrent UTIs
A new study shows that phage therapy – the use of tiny viruses to kill bacteria without harming people – could help to reduce recurrent infections, which happen when the bacteria responsible for UTIs ‘hide’ in the tissue of the bladder.